Literature DB >> 19577006

International consensus guidelines for surgical resection of mucinous neoplasms cannot be applied to all cystic lesions of the pancreas.

Mandeep S Sawhney1, Siwar Al-Bashir, Marcelo S Cury, Alphonso Brown, Ram Chuttani, Douglas K Pleskow, Mark P Callery, Charles M Vollmer.   

Abstract

BACKGROUND & AIMS: International consensus guidelines, aimed at predicting malignancy, are available for surgical resection of mucinous cysts but not for other cystic lesions of the pancreas. We sought to determine whether the consensus guidelines can be applied to all cystic lesions of the pancreas.
METHODS: We identified all patients who underwent surgical resection of pancreatic cysts from 2001-2007. Pathology analyses of surgical specimens served as the reference standard. Surgical resection criteria proposed by the Sendai Guidelines and 5 modifications of these criteria were tested to determine their accuracy for diagnosis of malignant cysts.
RESULTS: Patients with cystic lesions of the pancreas (n = 154; mean age, 59.8 years; 64% women) underwent resection and met prespecified study criteria. Twenty-one patients had a malignancy. The classification cyst size > or = 3 cm had an accuracy of 56%, negative predictive value of 84%, and identified only 57% of the malignant cysts. The classification cyst size > or = 3 cm or cyst with main pancreatic duct > or = 10 mm had an accuracy of 55%, negative predictive value of 86%, and identified 66% of malignant cysts. The modified criterion of cyst size > or = 3 cm or cyst with main pancreatic duct > 3 mm had an accuracy of 48%, negative predictive value of 94%, and identified 91% (19/21) of the malignancies. Cyst size (odds ratio, 1.05) and pancreatic duct dilation > 3 mm (odds ratio, 10.5) were strong and independent predictors of malignancy.
CONCLUSIONS: When applied to all cystic lesions of the pancreas, the international consensus criteria cause some malignant cysts to be missed. Modified criteria could identify most malignant cysts, although overall accuracy remains low.

Entities:  

Mesh:

Year:  2009        PMID: 19577006     DOI: 10.1016/j.cgh.2009.06.026

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  20 in total

1.  Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Hanno Matthaei; Alexis L Norris; Athanasios C Tsiatis; Kelly Olino; Seung-Mo Hong; Marco dal Molin; Michael G Goggins; Marcia Canto; Karen M Horton; Keith D Jackson; Paola Capelli; Giuseppe Zamboni; Laura Bortesi; Toru Furukawa; Shinichi Egawa; Masaharu Ishida; Shigeru Ottomo; Michiaki Unno; Fuyuhiko Motoi; Christopher L Wolfgang; Barish H Edil; John L Cameron; James R Eshleman; Richard D Schulick; Anirban Maitra; Ralph H Hruban
Journal:  Ann Surg       Date:  2012-02       Impact factor: 12.969

2.  Decision making for pancreatic resection in patients with intraductal papillary mucinous neoplasms.

Authors:  Bin Xu; Wei-Xing Ding; Da-Yong Jin; Dan-Song Wang; Wen-Hui Lou
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

3.  Comparison of surgical and endoscopic sample collection for pancreatic cyst fluid biomarker identification.

Authors:  Katie Partyka; Mitchell McDonald; Kevin A Maupin; Randall Brand; Richard Kwon; Diane M Simeone; Peter Allen; Brian B Haab
Journal:  J Proteome Res       Date:  2012-04-04       Impact factor: 4.466

Review 4.  Cystic pancreatic lesions: From increased diagnosis rate to new dilemmas.

Authors:  S Nougaret; L Mannelli; M-A Pierredon; V Schembri; B Guiu
Journal:  Diagn Interv Imaging       Date:  2016-11-11       Impact factor: 4.026

Review 5.  Pancreatic cystic lesions: when to watch, when to operate, and when to ignore.

Authors:  Brian G Turner; William R Brugge
Journal:  Curr Gastroenterol Rep       Date:  2010-04

6.  International guidelines for the management of pancreatic intraductal papillary mucinous neoplasms.

Authors:  Brian K P Goh
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

7.  Predictive value of serum carbohydrate antigen 19-9 in malignant intraductal papillary mucinous neoplasms.

Authors:  Bin Xu; Wen-Yan Zheng; Da-Yong Jin; Wei-xing Ding; Wen-Hui Lou; Lajeswar Ramsohok
Journal:  World J Surg       Date:  2011-05       Impact factor: 3.352

8.  Intraductal papillary mucinous neoplasm and the pancreatic incidentaloma.

Authors:  Tara S Kent; Charles M Vollmer; Mark P Callery
Journal:  World J Gastrointest Surg       Date:  2010-10-27

Review 9.  Cystic precursors to invasive pancreatic cancer.

Authors:  Hanno Matthaei; Richard D Schulick; Ralph H Hruban; Anirban Maitra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-03       Impact factor: 46.802

Review 10.  F18-FDG-PET/CT for evaluation of intraductal papillary mucinous neoplasms (IPMN): a review of the literature.

Authors:  Francesco Bertagna; Giorgio Treglia; Gian Luca Baiocchi; Raffaele Giubbini
Journal:  Jpn J Radiol       Date:  2013-01-12       Impact factor: 2.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.